The page lists 154 projects related to the topic "immunotherapy".
# | |||
---|---|---|---|
1 | APERIM | APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy | 2015 |
2 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
3 | IMMUNOSHAPE | Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells | 2015 |
4 | TREGeneration | Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes | 2015 |
5 | AllergyBLOCK | Blocking peanut allergy through protective IgG antibodies | 2015 |
6 | SO-CMA | Improving the safety of oral immunotherapy for cow's milk allergy in children | 2016 |
7 | DC cancer | Development and immunological control of dendritic cell cancer | 2015 |
8 | ImmunoFarm | IgA-based oral therapy for protection of piglets against infection with enterotoxigenic E. coli. | 2015 |
9 | VIRION | Viruses, Immune stimulation and RNA Interference in Oncology Network | 2015 |
10 | DermalTherapy | Membrane fusion mediated dermal allergy immunotherapy | 2015 |
11 | IMMUTRAIN | Training Network for the Immunotherapy of Cancer | 2015 |
12 | TIPPDECRA | Tolerogenic immunotherapy with peptide-pulsed dendritic cells in rheumatoid arthritis | 2016 |
13 | LEGO | Multimodal glycoconjugates: a molecular Lego approach for antitumoral immunotherapy | 2015 |
14 | ISPIC | Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome | 2016 |
15 | HIV1ABTHERAPY | Antibody-Mediated Therapy of HIV-1 Infection | 2016 |
16 | H2020MM04 | DC-based immunotherapy to treat Malignant Mesothelioma | 2016 |
17 | STREAM | Strategies towards Excellence in Immuno-Oncology | 2016 |
18 | VACTRAIN | TWINNING ON DNA-BASED CANCER VACCINES | 2016 |
19 | AML-VACCiN | Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia | 2016 |
20 | PRECIOUS | Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy | 2016 |
21 | DynOMIS | Dynamic Origins of MHC class I Selector function | 2016 |
22 | PIM PROTEOMICS | Unravelling PIM kinase signal integration in the T cell response | 2017 |
23 | DISTRICT | DECIPHERING THE ROLE OF TRIB1 IN REGULATORY T CELLS | 2017 |
24 | AVITAG | Alphaviral Immunotherapy against Glioblastoma | 2016 |
25 | ADHERE | Aptamer nanostructures dual-targeted to the HER receptor family for cancer therapy | 2016 |
26 | CHEMCHECK | CHECKPOINTS IN CHECK: Novel Chemical Toolbox for Local Cancer Immunotherapy | 2016 |
27 | Immune-senescence | Dual targeting of senescence and tumor immunity for cancer therapy | 2016 |
28 | INTHER | Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy | 2016 |
29 | Project ACT | Automated autologous cell therapy system | 2016 |
30 | STRAVIR | Role of the stroma-derived ‘alarmin’ IL-33 in anti-viral immunity | 2016 |
31 | DeNovoImmunoDesign | Computational Design of Novel Functional Proteins for Immunoengineering | 2017 |
32 | BITCAT | Blocking Inhibition of T-cell Co-stimulation for Anti-tumour Therapy | 2017 |
33 | HYPOXIMMUNO | Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia | 2016 |
34 | SweetAim | Selective glycoimmuno-targeting for cancer therapy | 2016 |
35 | EURE-CART | EURopean Endeavour for Chimeric Antigen Receptor Therapies | 2017 |
36 | IMMUNOSABR | Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer | 2017 |
37 | EVOLVE | Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy | 2017 |
38 | STIMUNITY | Preclinical validation of a novel immunogenic composition to stimulate innate immunity | 2017 |
39 | GAIT | From symptom relief to disease modifying allergy treatment with Glycan-Allergen Immunotherapy | 2017 |
40 | POLYBOOST | POLYBOOST: Renovating the Polyclonal Immunotherapy | 2016 |
41 | LentiFactory | MAGIC (MAnufacturing of Gene delivery tools for Industrial and Clinical applications) | 2017 |
42 | BGCI | Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology | 2017 |
43 | GD TCR LIGAND | Identification of the ligand of a human public anti-HCMV/cancer γδ T cell receptor | 2017 |
44 | CMI2T IA | Harmless Clostridium bacteria as a highly targeted, continuous delivery system for immunomodulatory anti-cancer drugs | 2017 |
45 | SCALTIE | Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy | 2017 |
46 | DevoSignGammaDelta | Tracking γδ T cell development and TCRγδ proximal signalling | 2018 |
47 | Immunometabolomics | CD8+ T cell metabolism in anti-tumor response | 2017 |
48 | CD4CRISPR | A quorum sensing mechanism regulating CD4 T cell proliferation | 2017 |
49 | CINK | Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers | 2018 |
50 | PolyVac | Polysaccharide-based membrane for sublingual vaccination | 2017 |
51 | IC_IL_EC_2017 | Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers | 2018 |
52 | THAT IS HUNT | Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors | 2018 |
53 | TANTUMorNEUVACCINE | Neutrophil subtypes: distinct cellular targets for therapeutic intervention | 2017 |
54 | TIGITtherapy | TIGIT therapy for cancer treatment | 2017 |
55 | ACTICELL | Precision confiner for mechanical cell activation | 2017 |
56 | IMMOVA | Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease | 2017 |
57 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2017 |
58 | ImmuneCheckpointsAD | Immune checkpoint blockade for fighting Alzheimer’s disease | 2017 |
59 | FATE | Functional Biology of Hepatic CD8+ T cells | 2017 |
60 | Cellphmed | Accurate cell signatures for the advancement of personalized medicine | 2017 |
61 | ENLIGHTEN | INTEGRATION AND PROPAGATION OF IMMUNOLOGICAL SIGNALS DURING CANCER AND INFECTION | 2018 |
62 | INTACt | ImmuNogenomics TArgeting Cancer | 2017 |
63 | STEPUP | Synthetic DCs for a T cEll ProdUction Platform | 2017 |
64 | BioProbe-PIT | Local molecular profiling of tumor tissue sections: towards personalized immunotherapy | 2017 |
65 | LUPUSCARE | PRECISION CARE IN SYSTEMIC AUTOIMMUNITY: AN INTEGRATED MULTI-TISSUE/LEVEL APPROACH FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) | 2017 |
66 | VDJtargeting | Engineering T cells and B cells for Immunotherapy using V(D)J recombination | 2017 |
67 | IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer | 2017 |
68 | SENSIT | Sensitivity of human tumors to T cell attack | 2017 |
69 | TRACE | Transfer of multivirus-specific T-cells following transplantation | 2018 |
70 | CANCER-DC | Dissecting Regulatory Networks That Mediate Dendritic Cell Suppression | 2018 |
71 | TissueLymphoContexts | Tissue-resident Lymphocytes: Development and Function in “real-life” Contexts | 2018 |
72 | CANCER | Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life | 2018 |
73 | OncoSeq | OncoSeq: an innovative single-cell system for immunomonitoring | 2017 |
74 | ImmunoFit | Harnessing tumor metabolism to overcome immunosupression | 2018 |
75 | SI | Structural and functional characterization of the ICOS/ICOSL immune complex | 2018 |
76 | iaFRET | An amplified signal imaging software for prognosis of cancer enabling the evaluation of clinicalefficiency of personalised cancer treatments to an unprecedented level. | 2018 |
77 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
78 | SmallDrugRheuma | Discovery of Immune Therapeutic Targets and Immunomodulators for the Development of Novel Therapies in Rheumatoid Arthritis. | 2018 |
79 | IMMUNOMARK | Omics integration for precision cancer immunotherapy | 2018 |
80 | TCELLTIGIT | Structural characterization of immune signaling protein TIGIT using x-ray crystallography and cryo-electron microscopy | 2019 |
81 | UTILIUM | Unraveling The Immune Landscape In Uveal Melanoma | 2018 |
82 | SPeNTa-Brain | Synthetic Peptidic Nanovesicles for Targeting Paediatric Brain tumours | 2019 |
83 | ONCOTHERANOSTICS | Advanced Theranostic Nanomedicines for Oncology. Development of new combinatorial therapies for primary and metastatic Breast Cancer. | 2019 |
84 | Gal3-BrainMets | A novel immunotherapy against brain metastasis: Anti-Galectin-3 | 2019 |
85 | InTheMLLrBALL | Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia | 2018 |
86 | IMM-GNRs | Human IMMune profiling of Graphene NanoRibbons | 2018 |
87 | RE-IMMUNE | Intelligent Nano-encapsuled siRNA for Restoring Immune Cell Response to Cancer | 2019 |
88 | IN-3D-CAN | Instrumented 3D-Printed Miniature Muscles for Cardiotoxicity Screens of Cancer Therapies | 2018 |
89 | GDCOLCA | Understanding gamma delta T cells in colon cancer metastasis | 2018 |
90 | QuanTII | Quantitative T cell Immunology and Immunotherapy | 2018 |
91 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
92 | CARAMBA | SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease | 2018 |
93 | SOLUPORE | Solupore® - Enabling the Manufacture of Affordable New Treatments to Cure Cancer | 2018 |
94 | AllergyExplorer | Automation of novel multi-parameter allergy test that is cost-efficient and delivers instantly correct results | 2018 |
95 | Oncarin | A scientifically proven Microbiome immunotherapy for the treatment of colorectal cancer | 2018 |
96 | UNLEASHAD | Unleashing the curative potential of cancer immunotherapy | 2018 |
97 | SOMIT | Leveraging a novel platform technology to develop a first-in-class immunotherapy for Celiac Disease | 2018 |
98 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
99 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
100 | I-DireCT | Immune DIREcted and Cancer-selective immunoTherapy | 2019 |
101 | STIMUNO | Searching for novel strategies improving cancer immunotherapy | 2019 |
102 | COR1-TCELL | Analysis of the role for coronin 1-dependent cell density signalling in T-cell homeostasis | 2019 |
103 | MechanoIMM | Mechanical Immunoengineering for Enhanced T-cell Immunotherapy | 2018 |
104 | ImmunoCode | Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy | 2018 |
105 | NextGen IO | Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology | 2019 |
106 | POLYMMUNE | Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment | 2019 |
107 | TCRabX | Structural basis for the therapeutic efficiency of optimal-affinity T cell receptors | 2019 |
108 | CANCEREVO | Deciphering and predicting the evolution of cancer cell populations | 2019 |
109 | ImmunoBioSynth | Synergistic engineering of anti-tumor immunity by synthetic biomaterials | 2019 |
110 | AllergyVAX | Next generation allergen immunotherapy based on specifically modified recombinant hypoallergens | 2018 |
111 | iReceptor Plus | ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY | 2019 |
112 | SYNKIT | Synthetic Natural Killer Cells for Immunotherapy | 2020 |
113 | GlyCANswer | Decoding the Cancer Glycoproteome Driven Immune Response | 2019 |
114 | MHT-ImmunoEnhancer | Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment | 2019 |
115 | ImmunoMECH | High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment | 2019 |
116 | Need2immune | Personalized liposomal cancer vaccines within days by rapid formulation screening | 2019 |
117 | MGLycan | Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer | 2019 |
118 | ARGONAUT | ARGONAUT: from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy | 2019 |
119 | IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts | 2019 |
120 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
121 | PROTEUS | Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection | 2019 |
122 | ONCO-BOOST | Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies | 2019 |
123 | SPLITVAC | Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines | 2019 |
124 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2019 |
125 | VACCIBIOME | Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy | 2019 |
126 | ARTimmune | Programmable ARTificial immune systems to fight cancer | 2019 |
127 | Anti-L1CAM | Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients | 2019 |
128 | PAVE | A nanovaccine Approach for the treatment of Pancreatic Cancer | 2019 |
129 | HIL PT System | A revolutionary, cost effective, ultra-compact proton therapy system for cancer treatment | 2019 |
130 | ADAMtx | ADAMtx: Development of Alzheimer’s immunotherapy by harnessing the natural reparative properties of microglia | 2019 |
131 | Immune-Image | Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies | 2019 |
132 | QUALITOP | Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management | 2020 |
133 | MaxONCO | A cancer vaccine to boost body’s natural defences to fight chordoma and head and neck cancer | 2020 |
134 | ONCORELIEF | A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment. | 2020 |
135 | TrojanDC | TrojanDC | 2019 |
136 | Synthetic T-rEX | A synthetic biology approach for T cell exhaustion | 2020 |
137 | RARITY | RAtional design of canceR ImmunoTherapY: one size does not fit all | 2019 |
138 | InterTAU | Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs | 2020 |
139 | STI-001 | Turn Cancer Immunotherapy Effective in Most Patients | 2019 |
140 | HDM-FUN | Host directed medicine in invasive fungal infection | 2020 |
141 | MISTRAL | Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination | 2020 |
142 | ImmunoSep | Personalized immunotherapy in sepsis: a precision medicine based approach | 2020 |
143 | MATCH | Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research | 2020 |
144 | Meta-Targeting | Macro-Nanomedicine to Treat Metastatic Cancer | 2020 |
145 | TrojanDC | Harnessing dendritic cell reprogramming for cancer immunotherapy | 2020 |
146 | NATURE-ETN | Nucleic Acids for Future Gene Editing, Immunotherapy and Epigenetic Sequence Modification | 2020 |
147 | MelImmuneOrg | Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy | 2020 |
148 | TESTIMONY | Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity | 2020 |
149 | Hemstem | Targeting leukaemia by modulating hematopoietic stem cell competitiveness | 2020 |
150 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |
151 | MITafterVIT | Unravelling maintenance mechanisms of immune tolerance after termination of venom immunotherapy by means of clonal mast cell diseases | 2020 |
152 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |
153 | Immuno-Predictor | Mechanical Biomarkers for Prediction of Cancer Immunotherapy | 2020 |
154 | PRECISMEDLYM | Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine. | 2020 |